Andrew Balo

Andrew Balo

Director/Board Member at GLUCOTRACK, INC.

Net worth: 3 097 $ as of 31/05/2026

78 year
Health Technology
Consumer Services

Profile

Mr. Andrew K. Balo is an EVP-Clinical Affairs, Regulatory Strategy at DexCom, Inc. Mr. Balo was previously employed as a Vice President-Regulatory & Clinical Affairs by InnerCool Therapies, Inc., a VP-Quality, Regulatory & Clinical Affairs by St. Jude Medical LLC, and a Vice President-Rgulatory & Clinical Affairs by Endocardial Solutions, Inc. He received his undergraduate degree from the University of Maryland.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/01/2026 4,692 ( 0.07% ) 3 097 $ 31/05/2026

Andrew Balo active positions

CompaniesPositionStart
GLUCOTRACK, INC. Director/Board Member 14/06/2024

Former positions of Andrew Balo

CompaniesPositionEnd
DEXCOM, INC. Chief Tech/Sci/R&D Officer 24/03/2024
DexCom International Ltd.
Chief Tech/Sci/R&D Officer 24/03/2024
Chief Tech/Sci/R&D Officer 01/02/2002
ST JUDE MEDICAL INC Chief Tech/Sci/R&D Officer 01/01/1997
Chief Tech/Sci/R&D Officer -
See the detail of Andrew Balo's experience

Training of Andrew Balo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

DexCom International Ltd.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!